| Disease | Target Count | P-value |
|---|---|---|
| psoriasis | 6694 | 2.3e-88 |
| Astrocytoma, Pilocytic | 3081 | 9.0e-07 |
| osteosarcoma | 7950 | 1.7e-06 |
| ductal carcinoma in situ | 1745 | 4.2e-05 |
| group 4 medulloblastoma | 1855 | 1.3e-04 |
| invasive ductal carcinoma | 2951 | 2.3e-04 |
| breast carcinoma | 1638 | 5.7e-04 |
| Atopic dermatitis | 952 | 5.9e-04 |
| interstitial cystitis | 2312 | 6.4e-04 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 1.9e-03 |
| glioblastoma | 5792 | 1.9e-03 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 2.9e-03 |
| adult high grade glioma | 3801 | 3.8e-03 |
| fibroadenoma | 559 | 4.4e-03 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 7.1e-03 |
| subependymal giant cell astrocytoma | 2287 | 2.8e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Bipolar Disorder | 666 | 0.0 | 1.7 |
| Disease | log2 FC | p |
|---|---|---|
| adult high grade glioma | -1.100 | 3.8e-03 |
| Astrocytoma, Pilocytic | 1.800 | 9.0e-07 |
| Atopic dermatitis | -1.100 | 5.9e-04 |
| breast carcinoma | -1.400 | 5.7e-04 |
| ductal carcinoma in situ | -3.100 | 4.2e-05 |
| fibroadenoma | -1.800 | 4.4e-03 |
| glioblastoma | -1.700 | 1.9e-03 |
| group 4 medulloblastoma | -1.500 | 1.3e-04 |
| interstitial cystitis | -1.300 | 6.4e-04 |
| intraductal papillary-mucinous adenoma (... | -1.200 | 1.9e-03 |
| intraductal papillary-mucinous carcinoma... | -1.100 | 2.9e-03 |
| intraductal papillary-mucinous neoplasm ... | -1.400 | 7.1e-03 |
| invasive ductal carcinoma | -3.400 | 2.3e-04 |
| osteosarcoma | -4.809 | 1.7e-06 |
| psoriasis | -2.000 | 2.3e-88 |
| subependymal giant cell astrocytoma | -1.252 | 2.8e-02 |
MRSEGAAPGPAAPLCGALSLLLGALLGKVIEGHGVTDNIQRFSSLPPYLPVSYHILRAETSFFLKEANQD 1 - 70 LLRNSSLQARVESFFTYKTRQPPVLNASYGPFSVEKVVPLDLMLTSNFLGPTNKFSFDWKLKAHILRDKV 71 - 140 YLSRPKVQVLFHIMGRDWDDHGAGEKLPCLRVFAFRETREVRGSCRLKGDLGLCVAELELLSSWFSAPTV 141 - 210 GAGRKKSMDQPEGTPVELYYTVHPGNERGDCAGGDFRKGNAIRPGKDGLEETTSHLQRIGTVGLYRAQDS 211 - 280 AQLSELRLDGNVVIWLPSRPVKQGEVVTAYVTISSNSSVDLFILRAKVKKGVNILSAQTREPRQWGVKQE 281 - 350 VGSGGKHVTATVACQRLGPSPRNRSSSLFNEVVQMNFEIASFSSLSGTQPITWQVEYPRKGTTDIAVSEI 351 - 420 FVSQKDLVGIVPLAMDTEILNTAVLTGKTVAMPIKVVSVEENSAVMDISESVECKSTDEDVIKVSERCDY 421 - 490 IFVNGKEIKGKMDAVVNFTYQYLSAPLCVTVWVPRLPLQIEVSDTELSQIKGWRVPIVTNKRPTRESEDE 491 - 560 DEEERRGRGCALQYQHATVRVLTQFVSEGAGPWGQPNYLLSPNWQFDITHLVADFMKLEEPHVATLQDSR 561 - 630 VLVGREVGMTTIQVLSPLSDSILAEKTITVLDDKVSVTDLAIQLVAGLSVALYPNAENSKAVTAVVTAEE 631 - 700 VLRTPKQEAVFSTWLQFSDGSVTPLDIYDTKDFSLAATSQDEAVVSVPQPRSPRWPVVVAEGEGQGPLIR 701 - 770 VDMTIAEACQKSKRKSILAVGVGNVRVKFGQNDADSSPGGDYEEDEIKNHASDRRQKGQHHERTGQDGHL 771 - 840 YGSSPVEREEGALRRATTTARSLLDNKVVKNSRADGGRLAGEGQLQNIPIDFTNFPAHVDLPKAGSGLEE 841 - 910 NDLVQTPRGLSDLEIGMYALLGVFCLAILVFLINCATFALKYRHKQVPLEGQASMTHSHDWVWLGNEAEL 911 - 980 LESMGDAPPPQDEHTTIIDRGPGACEESNHLLLNGGSHKHVQSQIHRSADSGGRQGREQKQDPLHSPTSK 981 - 1050 RKKVKFTTFTTIPPDDSCPTVNSIVSSNDEDIKWVCQDVAVGAPKELRNYLEKLKDKA 1051 - 1108 //
